21 May 2024

HemaVision®: Diagnostic tool for Leukemia screening

A CE-IVD marked diagnostic tool which screens for 28 chromosomal translocations associated with Leukemia.


Features:

  • 28 translocations screened simultaneously
  • Sensitive qPCR method
  • Qualitative detection
  • Fast analyse time (only 4 hours)
  • Simple and rapid protocol
  • Tested and validated (CE-IVD marked)
  • Globally used for the initial screening of patients
  • Master mixes are delivered pre-aliquoted into the tubes for your qPCR instrument
  • Controls included in the run – only one run per sample

HemaVision® is an aid to diagnosis meant for the initial screening.

Our customers say:

“The HemaVision® kit allows us to obtain fast results and to give important information for the diagnosis and prognosis.

“HemaVision® has easier handling through ready to use mixes, faster and more concrete results.”

“The HemaVision® workflow is reliable, robust and easy test.”

Two HemaVision® panels

DNA Diagnostic A/S produces HemaVision in two panels:
HemaVision-7Q detects 7 of the most predominant translocations.
HemaVision-28Q detects 28 translocations. Predominant once translocations, as well as many rare translocations.

HemaVision-28QHemaVision-7Q
del(1)(p32) (STIL::TAL1) 
t(1;11) (p32;q23.3) (KMT2A::EPS15) 
t(1;11) (q21;q23.3) (KMT2A::MLLT11) 
t(1;19) (q23;p13) (TCF3::PBX1)t(1;19) (q23;p13) (TCF3::PBX1)
t(3;5) (q25;q34) (NPM1::MLF1) 
t(3;21) (q26;q22) (RUNX1::MECOM) 
t(4;11) (q21;q23.3) (KMT2A::AFF1)t(4;11) (q21;q23) (KMT2A::AFF1)
t(5;12) (q33;p13) (ETV6::PDGFRB) 
t(5;17) (q35;q21) (NPM1::RARA) 
t(6;9) (p23;q34) (DEK::NUP214) 
t(6;11) (q27;q23.3) (KMT2A::AFDN) 
t(8;21) (q22;q22) (RUNX1::RUNX1T1)t(8;21) (q22;q22) (RUNX1::RUNX1T1)
t(9;9) (q34;q34) (SET::NUP214) 
t(9;11) (p21.3;q23.3) (KMT2A::MLLT3) 
t(9;12) (q34;p13) (ETV6::ABL1) 
t(9,22) (q34;q11) (BCR::ABL1)t(9,22) (q34;q11) (BCR::ABL1)
t(10;11) (p12;q23.3) (KMT2A::MLLT10) 
t(11;17) (q23.3;q21) (KMT2A::MLLT6) 
t(11;17) (q23;q21) (ZBTB16::RARA) 
t(11;19) (q23.3;p13.1) (KMT2A::ELL) 
t(11;19) (q23.3;p13.3) (KMT2A::MLLT1) 
t(12;21) (p13;q22) (ETV6::RUNX1)t(12;21) (p13;q22) (ETV6::RUNX1)
t(12;22) (p13;q12) (ETV6::MN1) 
t(15;17) (q24;q21) (PML::RARA)t(15;17) (q24;q21) (PML::RARA)
inv(16) (p13;q22) (CBFB::MYH11)inv(16) (p13;q22) (CBFB::MYH11)
t(16;21) (p11;q22) (FUS::ERG) 
t(17;19) (q22;p13) (TCF3::HLF) 
t(X;11) (q13;q23.3) (KMT2A::FOXO4) 
View all HemaVision® products in our webshop

HemaVision®: Diagnostic tool for Leukemia screening

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support
Contact